Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.
Publication/Presentation Date
7-15-2020
Abstract
• PRES is potentially a complication of severe SARS-CoV-2 infection. • Consider PRES in COVID-19 patients with altered mentation. • Consider tight blood pressure control in ventilated patients with COVID-19. • Hypertensive encephalopathy may prolong ventilator times in COVID-19 patients.
Volume
414
First Page
116943
Last Page
116943
ISSN
1878-5883
Published In/Presented At
Kishfy, L., Casasola, M., Banankhah, P., Parvez, A., Jan, Y. J., Shenoy, A. M., Thomson, C., & AbdelRazek, M. A. (2020). Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. Journal of the neurological sciences, 414, 116943. https://doi.org/10.1016/j.jns.2020.116943
Disciplines
Medicine and Health Sciences
PubMedID
32474362
Department(s)
Department of Medicine
Document Type
Article
COinS